Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100854
Status:
COMPLETED
Last Update Posted:
2019-03-05
First Post:
2005-01-06
Brief Title:
Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Translational Oncology Research International
Organization:
Translational Oncology Research International